Table of Contents Table of Contents
Previous Page  E161 844 Next Page
Show Menu
Previous Page E161 844 Next Page
Page Background

Corrigendum re: ‘‘Serum Levels of MicroRNA miR-371a-3p:

A Sensitive and Specific New Biomarker for Germ Cell Tumours’’

[Eur Urol 2017;71:213–20]

Klaus-Peter Dieckmann

a , * ,

Arlo Radtke

b ,

Meike Spiekermann

b ,

Thomas Balks

a ,

Cord Matthies

c ,

Pascal Becker

c ,

Christian Ruf

c ,

Christoph Oing

d ,

Karin Oechsle

d ,

Carsten Bokemeyer

d ,

Johannes Hammel

e ,

Sebastian Melchior

e ,

Werner Wosniok

f ,

Gazanfer Belge



Department of Urology, Albertinen Krankenhaus, Hamburg, Germany;


Centre for Human Genetics, University of Bremen, Bremen, Germany;



of Urology, Bundeswehr Krankenhaus, Hamburg, Germany;


Department of Medical Oncology, Universita¨tsklinikum Hamburg-Eppendorf, Hamburg,



Department of Urology, Zentralklinikum Bremen, Bremen, Germany;


Institute of Statistics, University of Bremen, Bremen, Germany

We write to clarify our conflicts of interest for this work. Klaus-Peter Dieckmann, Meike Spiekermann, and Gazanfer Belge

hold stock in miRdetect GmbH, Bremen, a biotech company aiming to develop a commercial laboratory test for measuring

microRNAs in body fluids. The miRdetect venture was formally registered as a legal entity in the Unternehmensregister

(German Business Register) on March 12, 2015 to avail of small/medium enterprise funding and to protect the name

miRdetect. Two of the authors (G. Belge and M. Spiekermann) each owned 20% of that enterprise. After submission of this

manuscript to

European Urology

, Meike Spiekermann was employed by miRdetect GmbH (since May 2016). miRdetect

became an active company with GmbH status with office rooms, employees, a Chief Executive Officer, and regular financial

transactions on April 11, 2016. miRdetect GmbH holds a patent for measurement of microRNAs in body fluids at the limit of

detection. The remaining authors have no conflicts of interest to disclose.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) e 1 6 1

ava ilable at

journal homepage:

DOI of original article:


* Corresponding author. Department of Urology, Albertinen Krankenhaus, Suentelstrasse 11a, D-22457 Hamburg, Germany. Tel. +40 55 882253;

Fax: +40 55 882381.

E-mail address:

(K.-P. Dieckmann).